Explore content related to EVOBYTE Digital Biology products and services
-
LOINC Data Standard: A common language for lab results
LOINC Data Standard gives every observation a precise, universal code, unifying results across EHRs, LIMS, and analytics for interoperable data.
-
AI in Quality Control: Praktische Lab AI Use Cases, die den Durchsatz steigern und Abweichungen reduzieren
Rückstände, späte Freigaben und wiederkehrende Abweichungen zehren an der QC-Kapazität. AI in Quality Control verwandelt die Daten, die Sie bereits […]
-
Spatial Transcriptomics Meets Single‑Cell RNA‑seq: Rebuilding Tissue Context Without Losing Resolution
By EVOBYTE: Your partner in bioinformatics Introduction Single‑cell RNA‑seq (scRNA‑seq) gives you a detailed inventory of cell states, but it […]
-
Cloud LIMS: Lower Costs, Faster Deployment, And Multi-Site Collaboration
Pressure to deliver results faster is real. Cloud LIMS helps labs cut costs, go live quickly, and work seamlessly across […]
-
Cloud LIMS: Niedrigere Kosten, schnellere Einführung und standortübergreifende Zusammenarbeit
Der Druck, Ergebnisse schneller zu liefern, ist real. Cloud LIMS hilft Laboren, Kosten zu senken, schneller live zu gehen und […]
-
Generative AI for Drug Design: Diffusion Models Reshape Molecular Discovery
Introduction If you’ve watched image generators take over creative tasks, a similar revolution is now happening in molecular discovery. Generative […]
-
21 CFR Part 11 Made Simple: Audit Trails and E‑Signatures in LIMS and ELN
Paper slows you down; regulators don’t accept guesswork. Here’s how to make 21 CFR Part 11 work for you—so your […]
-
21 CFR Part 11 leicht gemacht: Audit Trails und E‑Signatures in LIMS und ELN
Papier bremst Sie aus; Aufsichtsbehörden akzeptieren keine Vermutungen. So machen Sie 21 CFR Part 11 für sich nutzbar – damit […]
-
From EHR to Insight: Harmonizing Real‑World Data with FHIR and OMOP for Clinical Trial Enrichment
Introduction Electronic health records (EHRs) are overflowing with clues about how treatments work outside the pristine walls of randomized trials. […]